» Authors » Taiichi Hikichi

Taiichi Hikichi

Explore the profile of Taiichi Hikichi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 429
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K, et al.
Retina . 2024 Oct; 45(2):335-344. PMID: 39423137
Purpose: To assess the real-world outcome of best-corrected visual acuity after 2-year intervention for treatment-naive diabetic macular edema since the approval of anti-vascular endothelial growth factor therapy. Methods: A total...
2.
3.
Hikichi T
Jpn J Ophthalmol . 2023 Oct; 67(6):652-656. PMID: 37861941
Purpose: To investigate the outcomes and patient satisfaction at 6-months' follow-up after switching to faricimab to treat neovascular age-related macular degeneration (nAMD) with a treat-and-extend (TAE) regimen. Study Design: Retrospective...
4.
Hikichi T, Kubo N, Tabata M, Kurabe H
Retina . 2023 May; 44(9):1495-1503. PMID: 37224464
Purpose: To investigate predictors of recurrent exudation in choroidal neovascularization (CNV) of pachychoroid neovasculopathy after photodynamic therapy (PDT). Methods: Consecutive, treatment-naïve, symptomatic patients with pachychoroid neovasculopathy with subfoveal retinal fluid...
5.
Hikichi T, Kubo N, Tabata M
Can J Ophthalmol . 2022 Jun; 58(5):472-479. PMID: 35718024
Objective: To investigate the participation of residual fragments of epiretinal membranes (ERMs) in recurrent ERMs after pars plana vitrectomy (PPV) for ERMs. Design: Retrospective comparison study. Participants: Consecutive 195 eyes...
6.
Kusuhara S, Shimura M, Kitano S, Sugimoto M, Muramatsu D, Fukushima H, et al.
J Diabetes Investig . 2022 Apr; 13(8):1339-1346. PMID: 35389565
Aims/introduction: In older patients, the management of diabetic macular edema (DME) can be complicated by comorbidities, geriatric syndrome, and socioeconomic status. This study aims to evaluate the effects of aging...
7.
Hikichi T
Graefes Arch Clin Exp Ophthalmol . 2022 Mar; 260(8):2529-2535. PMID: 35235038
Purpose: To investigate the efficacy of sub-Tenon's capsule triamcinolone acetonide (STTA) injections for preventing development of intraocular inflammation (IOI) related to intravitreal injection (IVI) of brolucizumab for neovascular age-related macular...
8.
Hikichi T, Kubo N, Yamauchi M
Eye (Lond) . 2021 Feb; 35(12):3367-3375. PMID: 33564138
Background: To compare 1-year outcomes between anti-vascular endothelial factor (VEGF) therapy and half-dose photodynamic therapy (PDT) for treatment-naive pachychoroid neovasculopathy (PNV) with subretinal fluid (SRF). Methods: Consecutive patients with treatment-naive...
9.
Hikichi T
Jpn J Ophthalmol . 2021 Feb; 65(2):208-214. PMID: 33543351
Introduction: To report the development of intraocular inflammation (IOI) in three Japanese patients in the same clinic after intravitreal injections (IVI) of brolucizumab to treat neovascular age-related macular degeneration. Cases...
10.
Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, et al.
Br J Ophthalmol . 2020 Mar; 104(12):1755-1761. PMID: 32169861
Background/aims: To investigate the yearly change of real-world outcomes for best corrected visual acuity (BCVA) after 2-year clinical intervention for treatment-naïve diabetic macular oedema (DMO). Methods: Retrospective analysis of aggregated,...